Skip to main navigation Skip to search Skip to main content

Developing a toolkit for the assessment and monitoring of musculoskeletal ageing

  • Graham J. Kemp
  • , Fraser Birrell
  • , Peter D. Clegg
  • , Daniel J. Cuthbertson
  • , Giuseppe De Vito
  • , Jaap H. Van Dieën
  • , Silvia Del Din
  • , Richard Eastell
  • , Patrick Garnero
  • , Katarzyna Goljanek-Whysall
  • , Matthias Hackl
  • , Richard Hodgson
  • , Malcolm J. Jackson
  • , Sue Lord
  • , Claudia Mazzà
  • , Anne McArdle
  • , Eugene V. McCloskey
  • , Marco Narici
  • , Mandy J. Peffers
  • , Stefano Schiaffino
  • John C. Mathers

Research output: Contribution to JournalReview articleAcademicpeer-review

Abstract

The complexities and heterogeneity of the ageing process have slowed the development of consensus on appropriate biomarkers of healthy ageing. The Medical Research Council-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) is a collaboration between researchers and clinicians at the Universities of Liverpool, Sheffield and Newcastle. One of CIMA's objectives is to 'Identify and share optimal techniques and approaches to monitor age-related changes in all musculoskeletal tissues, and to provide an integrated assessment of musculoskeletal function'-in other words to develop a toolkit for assessing musculoskeletal ageing. This toolkit is envisaged as an instrument that can be used to characterise and quantify musculoskeletal function during 'normal' ageing, lend itself to use in large-scale, internationally important cohorts, and provide a set of biomarker outcome measures for epidemiological and intervention studies designed to enhance healthy musculoskeletal ageing. Such potential biomarkers include: Biochemical measurements in biofluids or tissue samples, in vivo measurements of body composition, imaging of structural and physical properties, and functional tests. This review assesses candidate biomarkers of musculoskeletal ageing under these four headings, details their biological bases, strengths and limitations, and makes practical recommendations for their use. In addition, we identify gaps in the evidence base and priorities for further research on biomarkers of musculoskeletal ageing.

Original languageEnglish
Pages (from-to)iv1-iv19
Number of pages19
JournalAge and Ageing
Volume47
Issue numberSuppl_4
DOIs
Publication statusPublished - 1 Sept 2018

Bibliographical note

Published [online]: 07 September 2018

Funding

Eugene McCloskey has been in receipt of research funds from Roche Diagnostics and speaker fees from GE Lunar, Hologic, Roche, Vertec Scientific. Matthias Hackl is a shareholder and employee of TAmiRNA GmbH, which is a private company involved in the development of in vitro diagnostic tests. Richard Eastell has received grant funding and consultancy from Immunodiagnostics Systems and Roche Diagnostics. This work was supported by the Medical Research Council (MRC) and Arthritis Research UK as part of the MRC— Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) [MR/K006312/1; MR/P020941/1]. The MRC—Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing is a The authors thank Louise Jaeger-Wright, CIMA Centre Manager, Institute of Ageing and Chronic Disease, University of Liverpool for administrative support throughout the preparation of this manuscript. We also thank Dr Penny Gray, of Penny Gray and Associates, for medical writing and editorial support, which was funded by the MRC—Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) in accordance with Good Publication Practice (GPP3) guidelines (http:// www.ismpp.org/gpp3).

FundersFunder number
Roche Diagnostics
Immunodiagnostics Systems and Roche
Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing
Centre for Ageing Research and Development in Ireland
UK Research and Innovation
Arthritis Research UK
National Institute on AgingP01AG051442
Wellcome Trust107471
Chartered Institute of Management AccountantsMR/K006312/1, GPP3
Medical Research CouncilMR/L016354/1, MR/P020941/1
Biotechnology and Biological Sciences Research CouncilBB/L021668/1

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • biomarkers
    • bone
    • cartilage
    • healthy ageing
    • musculoskeletal ageing
    • skeletal muscle

    Fingerprint

    Dive into the research topics of 'Developing a toolkit for the assessment and monitoring of musculoskeletal ageing'. Together they form a unique fingerprint.

    Cite this